
Flahy is the intelligence layer for better healthcare decisions.
We combine genomics with health and clinical context to guide more personalized prevention, diagnosis, and care.
Biological data is becoming increasingly available across healthcare, from genomics to broader clinical and health signals. But translating that data into meaningful decisions remains difficult.
Flahy exists to bridge that gap.
We are building systems that help turn biological and clinical information into actionable next steps — supporting more personalized, context-aware decisions across prevention and treatments.
Our consumer offering brings genomics into prevention and everyday health decisions, helping individuals better understand their biology and make more informed choices over time.
Our clinical decision support offering helps bring genomics into care pathways, supporting more personalized, guideline-aligned decisions in real-world clinical settings.
Flahy is being applied across multiple areas of care, including internal medicine, oncology, neurology, psychiatry, cardiology, paediatrics, and beyond, through specialized product modules such as FlahyCX, FlahyOX, FlahyOX-G, FlahyNG, & FlahyPX.
We believe the future of healthcare will depend on connecting biology, health data, and clinical context more intelligently.
Flahy is building that future — starting with genomics and expanding toward a broader intelligence layer for better healthcare decisions over time.

Founder & Chief Executive Officer

Christopher Mason

Raul Rabadan

Andrew Blumberg

Kaja Wasik

Arun Goyal